WO1991013167A1
(en)
*
|
1990-02-26 |
1991-09-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Identification and expression of insect steroid receptor dna sequences
|
ES2123569T3
(es)
*
|
1991-08-08 |
1999-01-16 |
Genentech Inc |
Regulacion de genes en celulas de mamifero dependiente de ecdiesteroides.
|
CA2115452A1
(en)
*
|
1991-09-17 |
1993-04-01 |
Ronald M. Evans |
Receptor of the thyroid/steroid hormone receptor superfamily
|
US5932699A
(en)
*
|
1995-01-13 |
1999-08-03 |
The General Hospital Corporation |
Retinoid X receptor-interacting polypeptides
|
ES2237764T3
(es)
|
1995-03-03 |
2005-08-01 |
Syngenta Participations Ag |
Control de la expresion genica en plantas por transactivacion mediada por un receptor en presencia de un ligando quimico.
|
CA2219121A1
(en)
*
|
1995-05-26 |
1996-11-28 |
Zeneca Limited |
A gene switch comprising an ecdysone receptor
|
US5728548A
(en)
*
|
1995-06-29 |
1998-03-17 |
Genetics Institute, Inc. |
Retinoid receptor-1 (RR1) and DNA encoding RR1
|
CN1202202A
(zh)
|
1995-10-10 |
1998-12-16 |
诺瓦提斯公司 |
保幼激素或其激动剂之一作为以受体介导的反式激活控制植物基因表达的化学配体
|
IL126418A0
(en)
*
|
1996-04-05 |
1999-05-09 |
Salk Inst For Biological Studi |
Hormone-mediated methods for modulating expression of exogenous genes and pharmaceutical compositions for modulating the same
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
US5851800A
(en)
*
|
1996-05-14 |
1998-12-22 |
Pharmacia & Upjohn Ab |
Process for producing a protein
|
US6610828B1
(en)
|
1996-05-24 |
2003-08-26 |
Syngenta Limited |
Heliothis ecdysone receptor
|
JP2000512135A
(ja)
*
|
1996-05-31 |
2000-09-19 |
アメリカン シアナミド コンパニー |
エクジソン受容体リガンドの選別方法
|
US6110698A
(en)
*
|
1996-05-31 |
2000-08-29 |
American Cyanamid Company |
Screen for ultraspiracle inhibitors
|
CA2257110A1
(en)
*
|
1996-05-31 |
1997-12-04 |
American Cyanamid Company |
Screen for ultraspiracle inhibitors
|
US6893830B1
(en)
*
|
1996-09-27 |
2005-05-17 |
The Board Of Regents Of The University Of Texas System |
Method of screening oxysterol activation of LXRα
|
US7119190B2
(en)
*
|
1997-04-14 |
2006-10-10 |
Arena Pharmaceuticals, Inc. |
Endogenous and non-endogenous versions of human G protein-coupled receptors
|
US6555339B1
(en)
|
1997-04-14 |
2003-04-29 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human protein-coupled receptors
|
ATE423313T1
(de)
*
|
1997-04-14 |
2009-03-15 |
Arena Pharm Inc |
Methode zum identifizieren von modulatoren der zelloberflächenmembranrezeptoren,nützlich zur behandlung von krankheiten
|
AUPP135698A0
(en)
*
|
1998-01-15 |
1998-02-05 |
Commonwealth Scientific And Industrial Research Organisation |
Insectical modalities
|
US6653086B1
(en)
|
1998-04-14 |
2003-11-25 |
Arena Pharmaceuticals, Inc. |
Endogenous constitutively activated G protein-coupled orphan receptors
|
US6420563B1
(en)
|
1998-07-31 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of G protein-coupled receptor six
|
JP2002525053A
(ja)
|
1998-09-10 |
2002-08-13 |
パイオニア ハイ−ブレッド インターナショナル, インコーポレイテッド |
エクジソンレセプターおよびそれらの使用のための方法
|
US20030229216A1
(en)
*
|
1998-10-13 |
2003-12-11 |
Ruoping Chen |
Constitutively activated human G protein coupled receptors
|
US20040137563A9
(en)
*
|
1998-10-13 |
2004-07-15 |
Ruoping Chen |
Endogenous and non-endogenous versions of human G protein-coupled receptors
|
US20070072248A1
(en)
*
|
1998-10-13 |
2007-03-29 |
Arena Pharmaceuticals, Inc. |
Constitutively activated human G protein coupled receptors
|
US20030139588A9
(en)
*
|
1998-10-13 |
2003-07-24 |
Ruoping Chen |
Endogenous and non-endogenous versions of human G protein-coupled receptors
|
US20030017528A1
(en)
*
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
US7816492B2
(en)
*
|
1998-11-20 |
2010-10-19 |
Arena Pharmaceuticals, Inc. |
Human G protein-coupled receptors
|
USRE42190E1
(en)
|
1998-11-20 |
2011-03-01 |
Arena Pharmaceuticals, Inc. |
Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
|
US6287813B1
(en)
|
1999-04-23 |
2001-09-11 |
Cistronics Cell Technology Gmbh |
Antibiotic-based gene regulation system
|
AU771153B2
(en)
*
|
1999-07-01 |
2004-03-18 |
Commonwealth Scientific And Industrial Research Organisation |
Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor
|
AU7487300A
(en)
*
|
1999-09-16 |
2001-04-17 |
Genoptera, Llc |
Lethal insectidice targets
|
US20030217376A1
(en)
*
|
1999-12-08 |
2003-11-20 |
Ebens Allen James |
Insecticide targets and methods of use
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
US7122172B1
(en)
|
2000-03-08 |
2006-10-17 |
Gerhart Graupner |
Methods and compositions for targeted drug delivery
|
US7906103B2
(en)
*
|
2000-03-08 |
2011-03-15 |
Gerhard Graupner |
Methods and compositions for targeted drug delivery
|
DE10013618A1
(de)
*
|
2000-03-18 |
2001-09-20 |
Bayer Ag |
Rezeptoren für Peptide aus Insekten
|
US20040033600A1
(en)
*
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
CA2413673C
(en)
|
2000-06-28 |
2018-01-09 |
Amgen Inc. |
Thymic stromal lymphopoietin receptor molecules and uses thereof
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
US6576422B1
(en)
|
2000-10-17 |
2003-06-10 |
Rohm And Haas Company |
Method for identifying products employing gene expression
|
US6958236B2
(en)
|
2000-10-24 |
2005-10-25 |
Syngenta Participations Ag |
Control of gene expression in plants
|
WO2002057455A2
(en)
*
|
2001-01-18 |
2002-07-25 |
Syngenta Participations Ag |
Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof
|
US9493540B2
(en)
|
2001-02-20 |
2016-11-15 |
Intrexon Corporation |
Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
|
JP4328094B2
(ja)
|
2001-02-20 |
2009-09-09 |
イントレクソン・コーポレイション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
DK1572862T3
(da)
|
2001-02-20 |
2012-11-26 |
Intrexon Corp |
Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
|
CA2438133C
(en)
|
2001-02-20 |
2015-01-27 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
US7177763B2
(en)
*
|
2001-09-25 |
2007-02-13 |
Werner Keber |
Method and device for preventing unpermitted approach of airplanes to objects on the ground which are to be protected
|
EP1436394A4
(de)
*
|
2001-09-26 |
2004-12-29 |
Rheo Gene Holdings Inc |
Zikaden-ecdyson-rezeptor-nukleinsäuren, -polypeptide und ihre verwendungen
|
JP2005507247A
(ja)
|
2001-09-26 |
2005-03-17 |
レオジーン・ホールディングス,インコーポレーテッド |
コナジラミエクジソン受容体核酸、ポリペプチド、およびそれらの使用
|
US6902902B2
(en)
*
|
2001-11-27 |
2005-06-07 |
Arena Pharmaceuticals, Inc. |
Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
|
AU2003201649B2
(en)
|
2002-01-09 |
2008-01-24 |
Erasmus University Medical Center Rottendam |
Inducible transposition in transgenic organism using transposon vector
|
US20040025194A1
(en)
*
|
2002-02-22 |
2004-02-05 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
EP1487965A4
(de)
|
2002-02-25 |
2006-11-15 |
Mpex Pharmaceuticals Inc |
Minizellzusammensetzungen und -verfahren
|
GB2387599B
(en)
*
|
2002-04-17 |
2005-08-10 |
Jason Peter Brown |
Methods for producing antibodies
|
US7205147B2
(en)
*
|
2002-09-23 |
2007-04-17 |
E.I. Du Pont De Nemours And Company |
Nucleic acids encoding ryanodine receptors
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
US7304162B2
(en)
*
|
2003-02-21 |
2007-12-04 |
Intrexon Corporation |
Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
WO2005022167A2
(en)
|
2003-08-29 |
2005-03-10 |
The University Of North Carolina At Greensboro |
Compounds that act to modulate insect growth and methods and systems for identifying such compounds
|
US8637237B2
(en)
|
2003-08-29 |
2014-01-28 |
The University Of North Carolina At Greensboro |
Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides
|
US20050164210A1
(en)
*
|
2004-01-23 |
2005-07-28 |
Vivek Mittal |
Regulated polymerase III expression systems and related methods
|
US20050179647A1
(en)
*
|
2004-02-18 |
2005-08-18 |
Microsoft Corporation |
Automatic detection and switching between input modes
|
US7935510B2
(en)
*
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
US7892565B2
(en)
|
2004-09-01 |
2011-02-22 |
Allergan, Inc. |
Degradable clostridial toxins
|
ATE514709T1
(de)
|
2005-03-15 |
2011-07-15 |
Allergan Inc |
Modifizierte clostridientoxine mit erhöhter targeting-kapazität für endogene clostridientoxin-rezeptorsysteme
|
WO2008036060A2
(en)
|
2005-04-05 |
2008-03-27 |
Allergan, Inc. |
Clostridial toxin activity assays
|
DE602006013481D1
(de)
|
2005-09-19 |
2010-05-20 |
Allergan Inc |
Mit clostriedientoxin aktivierbare clostridientoxine
|
US20070212716A1
(en)
*
|
2006-02-10 |
2007-09-13 |
Commonwealth Scientific & Industrial Research Org. |
Nezara viridula Ecdysone Receptor
|
US20100167040A1
(en)
*
|
2006-07-25 |
2010-07-01 |
Bayer Bioscience N.V. |
Identification of a novel type of sucrose synthase and use thereof in fiber modification
|
NZ583992A
(en)
|
2007-09-17 |
2012-11-30 |
Rohm & Haas |
A gene expression system for controllable expression of ethylene response in a plant
|
US8052872B2
(en)
*
|
2008-02-13 |
2011-11-08 |
U.S. Peroxide Llc |
Methods and device for enhancement of anaerobic digestion
|
KR101609894B1
(ko)
|
2008-03-14 |
2016-04-08 |
알러간, 인코포레이티드 |
면역-기반 보툴리눔 독소 세로타입 a 활성 검정
|
WO2010070394A1
(en)
*
|
2008-12-17 |
2010-06-24 |
Universite Pierre Et Marie Curie-Paris Vi |
Modulators of the cx3cr1 receptor and therapeutic uses thereof
|
NZ595163A
(en)
|
2009-03-05 |
2013-04-26 |
Rohm & Haas |
Control of key ethylene hormone signaling pathway proteins in plants
|
KR20200146046A
(ko)
|
2009-03-13 |
2020-12-31 |
알러간, 인코포레이티드 |
면역 기반 보툴리눔 독소 혈청형 a 활성 검정에 유용한 세포
|
RU2543650C2
(ru)
|
2009-03-13 |
2015-03-10 |
Аллерган, Инк. |
Иммунологические тесты на активность эндопептидаз с измененной нацеленностью
|
AU2010353292A1
(en)
|
2009-12-16 |
2012-07-12 |
Allergan, Inc. |
Modified Clostridial toxins comprising an integrated protease cleavage site-binding domain
|
SG182691A1
(en)
|
2010-01-25 |
2012-08-30 |
Allergan Inc |
Methods of intracellular conversion of single-chain proteins into their di-chain form
|
CA2799969C
(en)
|
2010-05-20 |
2019-06-25 |
Allergan, Inc. |
Degradable clostridial toxins
|
CA2868292A1
(en)
*
|
2012-03-27 |
2013-10-03 |
National University Corporation Kumamoto University |
Immunodeficient mouse with humanized liver
|
MX361717B
(es)
|
2013-03-15 |
2018-12-14 |
Intrexon Corp |
Diacilhidrazinas que contienen boro.
|
US11053513B2
(en)
|
2013-07-15 |
2021-07-06 |
Donald Danforth Plant Science Center |
Enhanced oil production and stress tolerance in plants
|
AU2015317862A1
(en)
|
2014-09-17 |
2017-04-06 |
Intrexon Corporation |
Boron-containing diacylhydrazine compounds
|
CA3008641A1
(en)
|
2015-12-16 |
2017-06-22 |
Gritstone Oncology, Inc. |
Neoantigen identification, manufacture, and use
|
WO2019075112A1
(en)
|
2017-10-10 |
2019-04-18 |
Gritstone Oncology, Inc. |
IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS
|
WO2019104203A1
(en)
|
2017-11-22 |
2019-05-31 |
Gritstone Oncology, Inc. |
Reducing junction epitope presentation for neoantigens
|
JP2021508453A
(ja)
|
2017-12-20 |
2021-03-11 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
ボツリヌス毒素細胞結合ドメインポリペプチドおよび皮膚の若返りのための使用方法
|